DTU Logo
Publications | Conference abstracts | Slidesets | Webcasts

Publications (16 of 403)


Search Publications :

2008

UKPDS - The first 30 years
Holman RR, Watkins PJ
2008; :ISBN:978-1-4051-9166, Published:07-Apr-2015

The cost-effectiveness a disease management programme for secondary prevention of coronary heart disease and heart failure in primary care
D A Turner, S Paul, M A Stone, A Juarez-Garcia, I Squire, K Khunti
Heart 2008;94:1601-1606, Published:Dec-2008, Epub:01-May-2008, PMID:18450843, doi:10.1136/hrt.2007.125708
[Abstract]

Addition of Insulin to Oral Therapy in Type 2 Diabetes
Holman RR
N Eng J Med 2008;358:1198, Published:05-Nov-2008
[Full text]

Analysis of bedside entertainment services' effect on post cardiac surgery physical activity: a prospective, randomised clinical trial
Sotiris Papaspyros, Shitansu Uppal, Shakeeb A. Khan, Sanjoy Paul, David J. O'Regan
European Journal of Cardiothoracic Surgery 2008;34:1022-1026, Published:Nov-2008, Epub:15-Aug-2008, PMID:18706826, doi:10.1016/j.ejcts.2008.05.042
[Abstract]

10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
Rury R. Holman, Sanjoy K. Paul, M. Angelyn Bethel, David R. Matthews and H. Andrew W. Neil
N Eng J Med 2008;359:1577-89, Published:09-Oct-2008, Epub:10-Sep-2008, PMID:18784090, doi:10.1056/nejmoa0806470
[Slides]

Long-Term Follow-up after Tight Control of Blood Pressure in Type 2 Diabetes
Rury R. Holman, Sanjoy K. Paul, M. Angelyn Bethel, H. Andrew W. Neil and David R. Matthews
N Eng J Med 2008;359:1565-76, Published:09-Oct-2008, Epub:10-Sep-2008, PMID:18784091, doi:10.1056/nejmoa0806359
[Slides]

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: Rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial
Robert M. Califf, Mitradev Boolell, Steven M. Haffner, M. Angelyn Bethel, John McMurray, Anil Duggal, Rury R. Holman, for the NAVIGATOR Study Group
Am Heart J 2008;156:623-32, Published:Oct-2008, Epub:09-Sep-2008, PMID:18946890, doi:10.1016/j.ahj.2008.05.017

Determining the most appropriate components for a composite clinical trial outcome
M. Bethel, R. Holman, S. Haffner, R. Califf, A. Huntsman-Labed, T. Hua, J. McMurray
Am Heart J 2008;156:633-40, Published:Oct-2008, Epub:31-Jul-2008, PMID:18926145, doi:10.1016/j.ahj.2008.05.018

Impact of comorbid diabetes on quality of life and perception of angina pain in people with angina registered with general practitioners in the UK
Stone MA, Khunti K, Squire I, Paul S
Qual Life Res 2008;17:887-894, Published:Aug-2008, Epub:17-Jun-2008, PMID:18560992, doi:10.1007/s11136-008-9363-0

The impact of individualised cardiovascular disease (CVD) risk estimates and lifestyle advice on physical activity in individuals at high risk of CVD. A Pilot 2x2 Factorial understanding risk trial
Hermione C Price, Lynne Tucker, Simon J Griffin and Rury R Holman
Cardiovascular Diabetology 2008;7:21, Published:17-Jul-2008, PMID:18637168, doi:10.1186/1475-2840-7-21
[Abstract]

Predictability of price of tea from sensory assessments and biochemical information using data-mining techniques
Sanjoy K Paul
J Sci Food Agric 2008;88:1354-1362, Published:Jun-2008, Epub:09-Apr-2008, doi:10.1002/jsfa.3223

Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial
DREAM Trial Investigators; G.R. Dagenais, H.C. Gerstein, R. Holman, A. Budaj, A. Escalante, T. Hedner, M. Keltai, E. Lonn, S. McFarlane, M. McQueen, K. Teo, P. Sheridan, J. Bosch, J. Pogue, S. Yusuf
Diabetes Care 2008;31:1007-1014, Published:May-2008, Epub:11-Feb-2008, PMID:18268075, doi:10.2337/dc07-1868
[Abstract]

Rosiglitazone Associated Fractures in Type 2 Diabetes:an Analysis from A Diabetes Outcome Progression Trial (ADOPT).
Steven E. Kahn, Bernard Zinman, John M. Lachin, Steven M. Haffner, William H. Herman, Rury R. Holman, Barbara G. Kravitz, Dahong Yu, Mark A. Heise, R. Paul Aftring, Giancarlo Viberti, and for the A Diabetes Outcome Progression Trial (ADOPT) Study Group
Diabetes Care 2008;31:845-851, Published:May-2008, Epub:25-Jan-2008, PMID:18223031, doi:10.2337/dc07-2270
[Abstract]

Clinical decisions. Management of type 2 diabetes
Ronald B. Goldberg, Rury Holman, Daniel J. Drucker
N Eng J Med 2008;358:293-7, Published:17-Jan-2008, PMID:18199869, doi:10.1056/NEJMclde0708469

Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones
D. M. Nathan, J. B. Buse, M. B. Davidson, E. Ferrannini, R. R. Holman, R. Sherwin and B. Zinman
Diabetologia 2008;51:8-11, Published:07-Jan-2008, Epub:20-Nov-2007, PMID:18026926, doi:10.1007/s00125-007-0873-z
Erratum in :
Diabetologia 2008;51:522, Print:Mar-2008, doi:10.1007/s00125-007-0917-4

Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones
David M. Nathan, John B. Buse, Mayer B. Davidson, Ele Ferrannini, Rury R. Holman, Robert Sherwin and Bernard Zinman
Diabetes Care 2008;31:173-175, Published:Jan-2008, Epub:22-Oct-2008, PMID:18165348, doi:10.2337/dc08-9016